Attention is being focused on a side effect of Biogen’s Alzheimer’s drug, Aduhelm (aducanumab). Even before its controversial approval on June 7, there were cases of amyloid-related imaging abnormalities (ARIA‑E), or cerebral edema, observed in the trials. [Read more…] about Amyloid-related imaging abnormalities (ARIA) found in approximately 40% of patients taking “Alzheimer’s drug” Aduhelm
“For years, Ted Kaptchuk performed acupuncture at a tiny clinic in Cambridge, a few miles from his current office, at the Harvard Medical School. He opened for business in 1976, having just returned from Asia, where he had spent four years honing his craft. Not long after he arrived in Boston, he treated an Armenian woman for chronic bronchitis. A few weeks later, the woman returned with her husband and told Kaptchuk that he had “cured” her.” [Read more…] about Research: Could studying the placebo effect change the way we think about medicine?